According to a new report by Future Market Insights, the intubation tube market is expected to reach US$ 2.2 billion in sales in 2021 and develop at a compound yearly growth rate (CAGR) of 6.8% from 2022 to 2032. By the end of 2032, the market is projected to be valued US$ 4.5 billion. The revenue from normal intubation tubes is expected to increase by 2.2 times between 2022 and 2032.
COVID-19 has accelerated the growth of the Intubation Tubes market, as difficulty breathing is an indicator of infection. The American Association of Bronchology and Interventional Pulmonology recommends an open surgical tracheostomy (OST) or a percutaneous dilatational tracheostomy for COVID patients with respiratory failure. Emergency products are now being approved as a result of the pandemic.
Get a Sample Copy of the Report:
https://www.futuremarketinsights.com/reports/sample/rep-gb-15079
Biomedical company N8 Medical received emergency authorization in Canada for its CeraShield Intubation Tubes in mechanically ventilated patients with COVID-19. The anti-fouling coating on its patented product prevents the infection of dangerous microorganisms. Endotracheal intubation and ventilation let COVID-19 patients breathe so that their body can survive while the virus is being fought by the immune system. This means they will have a better chance of surviving the infection. Market growth is projected to be boosted by such scenarios.
Key Takeaways:
•Global Intubation Tube Market is estimated to reach a market size of US$ 2.3 Billion by 2022.
•The Orotracheal route type segment is expected to have the highest CAGR rate of 7.2% during the forecast period.
•United States to remain the most dominant market with absolute dollar opportunity of US$ 654.2 Million during 2022 to 2032.
•The market in China is set to experience the highest CAGR of 8.6% during 2022-2032.
“The rising frequency of chronic respiratory disease, the rising incidence of ventilator-associated pneumonia, increasing road accidents and trauma injuries, Increasing prevalence of cancer, lung injuries and cardiovascular diseases and technological developments in Intubation Tubes are expected to drive Intubation Tube market growth.” comments a Future Market Insights analyst.
Competitive Landscape :
Key players in Intubation Tube market are engaged in strategic activities of mergers and acquisitions along with new product releases in order to maintain market share and broaden their product portfolio.
•In August 2020, Bactiguard’s Intubation Tubes have been approved by Health Canada for the prevention of COVID-19 infection. The revolutionary device helps to reduce severe infection in severely unwell patients.
•In April 2020, Hydromer partnered with N8 Manufacturing being the exclusive licensee for the product CeraShield Intubation Tube, which is used to treat in intensive care units and mechanical ventilators during COVID-19 patients across Canada.
More Insights Available
Future Market Insights, in its new offering, presents an unbiased analysis of the Intubation Tube Market, presenting historical market data (2017 to 2021) and forecast statistics for the period of 2022 to 2032.
The study reveals extensive growth in Intubation Tube Market in terms of Product Type (Regular Intubation Tube, Reinforced Intubation Tube, Preformed Intubation Tube, Double lumen Intubation Tube), by Route type (Orotracheal, Nasotracheal), by Application (Emergency Treatment, Therapy and Others), by End User (Hospitals, Clinics, Ambulatory Surgical Centers and Others) across five regions (North America, Europe, Asia Pacific, Middle East & Africa and Latin America).
Unlock Tailored Insights: Customize Your Report for Maximum Impact:https://www.futuremarketinsights.com/customization-available/rep-gb-15079
Market Segments Covered In Intubation Tube Market Analysis
By Product Type:
•Regular Intubation Tube Market
•Reinforced Intubation Tube Market
•Preformed Intubation Tube Market
•Double lumen Intubation Tube Market
By Route Type:
•Orotracheal Tube
•Nasotracheal Tube
By Application:
•Emergency Treatment
•Therapy
•Other Applications
By Region:
•North America
•Europe
•APAC
•MEA
•Latin America
Author By:
Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.) holds over 12 years of experience in the Healthcare, Medical Devices, and Pharmaceutical industries. His curious and analytical nature helped him shape his career as a researcher.
Identifying key challenges faced by clients and devising robust, hypothesis-based solutions to empower them with strategic decision-making capabilities come naturally to him. His primary expertise lies in areas such as Market Entry and Expansion Strategy, Feasibility Studies, Competitive Intelligence, and Strategic Transformation.
Holding a degree in Microbiology, Sabyasachi has authored numerous publications and has been cited in journals, including The Journal of mHealth, ITN Online, and Spinal Surgery News.
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube
